XPO Q1 2026 Earnings EPS Beats Estimates by 14 but Stock Falls on Revenue Concerns MANH Q1 2026 Earnings EPS Surpasses Estimates as Supply Chain Software Demand Stabilizes Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress Arcadia Biosciences RKDA Q3 2025 Profit Surges Past Wall Street Targets Green Brick Partners Q1 2026 Earnings EPS Beats Estimates by 153 Amid Mixed Stock Reaction SOWG Q3 2025 Earnings Significant EPS Miss Highlights Operational Challenges